This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.
Since the global pandemic, COVID-19 has transitioned to an endemic phase, with ongoing circulation driven by reduced transmission prevention measures, waning immunity and viral evolution.1 Despite...
In the early days of the COVID-19 pandemic, researchers, drug developers and healthcare providers raced against the clock to find solutions to slow the spread of SARS-CoV-2 and successfully treat the...
The human cytomegalovirus (CMV) is a common virus belonging to the herpes virus family with a global seroprevalence of 40–100%.1–3 Although usually latent and asymptomatic, CMV is a lifelong...
There have been over 526 million confirmed cases and over 6 million deaths worldwide since the coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2...
Over the past decade, treatments for human immunodeficiency virus (HIV) infection have become more efficacious, safer and more satisfying from the patient’s perspective. Bictegravir (BIC) is the...
Fiona Marple-Clark,a Alison Bell,b Hamish Bowden,c David Crawford,d Vickie Knight,e Samantha Libertino,f Don E Smithc,g...
International guidelines for the management of human immunodeficiency virus (HIV) infection have been updated recently. In addition, there is emerging evidence on the use of dual therapies for the...
Fiona Marple-Clark,a Bruce Hamish Bowden,b Jayne Howard,c Ngaire Latch,d John McAllister,e Maggie Smith,b Leah Williamsf...
Einleitung Die in den letzten zwanzig Jahren erzielten Fortschritte in der antiretroviralen Therapie (ART) ermöglichen HIV-infizierten Menschen heute eine weitgehend normale Lebenserwartung (1)....
Overall prevalence of HIV in Europe Since surveillance of the HIV epidemic began, more than half a million (504,455) HIV diagnoses have been reported in EU/EEA countries (Austria, Belgium,...